Search results
Inflammatory disease biotech launches with $168M and ex-Kite leader at the helm
FierceBiotech· 5 days agoWith a former Kite Pharma leader at the helm, Santa Ana Bio has unveiled with $168 million and three...
Putting the brakes on chronic inflammation: Study discovers link between two key pathways
Medical Xpress· 5 days agoThe immune system has many pathways to protect the body from infection, but sometimes an overactive immune response results in autoimmune diseases including IBD, psoriasis, rheumatoid ...
Amgen Notifies Consumers of Data Breach Stemming from Coding Error | JD Supra
JD Supra· 5 days agoOn August 23, 2023, Amgen Inc. filed a notice of data breach with the Attorney General of Montana after discovering that patient information was made available to an unauthorized party. In this ...
Try These Expert-Recommended Psoas Stretches for Pain Relief and Better Mobility
Prevention· 4 days agoWhile there are a variety of moves that can help address certain issues (like lower back pain), a...
Try These Expert-Recommended Psoas Stretches for Pain Relief and Better Mobility
Prevention via Yahoo News· 4 days agoPsoas stretches can help relieve and lengthen tight muscles. Here, experts share exercises, like leg...
The gut microbiome could affect cardiovascular health and how we age
MedicalNewsToday via AOL· 3 days agoResearchers in China have shown that metabolic health is linked to the presence and abundance of...
Celine Dion Opens Up About Living with Stiff Person Syndrome
Healthline via AOL· 7 days agoIn a new interview with TODAY’s Hoda Kotb, music icon Celine Dion opened up about her journey living...
7 A-Rated Biotech Stocks Worth Betting On in June
InvestorPlace· 4 days agoLet me be clear: investing in biotech stocks isn’t for everyone. Investing in smaller biotech companies requires research, patience, and risk tolerance....
Late-breaking results show nipocalimab significantly improves Sjögren's disease activity in a Phase...
FOX 23 News Albany· 3 days agoJohnson & Johnson (NYSE: JNJ) announces patients treated with nipocalimab demonstrated statistically...